Glenview Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Buy |
1,619
+475
| +42% | +$185K | 0.01% | 342 |
|
|
2025
Q1 | $498K | Buy |
1,144
+106
| +10% | +$46.1K | 0.01% | 360 |
|
|
2024
Q4 | $383K | Sell |
1,038
-391
| -27% | -$144K | 0.01% | 387 |
|
|
2024
Q3 | $743K | Sell |
1,429
-29
| -2% | -$15.1K | 0.01% | 298 |
|
|
2024
Q2 | $790K | Sell |
1,458
-541
| -27% | -$293K | 0.02% | 278 |
|
|
2024
Q1 | $1.04M | Sell |
1,999
-54
| -3% | -$28K | 0.02% | 253 |
|
|
2023
Q4 | $968K | Buy |
2,053
+713
| +53% | +$336K | 0.02% | 249 |
|
|
2023
Q3 | $583K | Buy |
1,340
+148
| +12% | +$64.4K | 0.02% | 293 |
|
|
2023
Q2 | $530K | Buy |
1,192
+30
| +3% | +$13.3K | 0.01% | 309 |
|
|
2023
Q1 | $534K | Buy |
1,162
+283
| +32% | +$130K | 0.02% | 310 |
|
|
2022
Q4 | $451K | Buy |
879
+64
| +8% | +$32.8K | 0.01% | 316 |
|
|
2022
Q3 | $370K | Sell |
815
-13
| -2% | -$5.9K | 0.01% | 318 |
|
|
2022
Q2 | $400K | Buy |
828
+50
| +6% | +$24.2K | 0.01% | 318 |
|
|
2022
Q1 | $382K | Buy |
778
+104
| +15% | +$51.1K | 0.01% | 340 |
|
|
2021
Q4 | $312K | Buy |
674
+5
| +0.7% | +$2.32K | 0.01% | 357 |
|
|
2021
Q3 | $249K | Sell |
669
-39
| -6% | -$14.5K | 0.01% | 364 |
|
|
2021
Q2 | $270K | Sell |
708
-1,060
| -60% | -$404K | 0.01% | 362 |
|
|
2021
Q1 | $635K | Buy |
1,768
+1,061
| +150% | +$381K | 0.03% | 224 |
|
|
2020
Q4 | $227K | Buy |
+707
| New | +$227K | 0.01% | 322 |
|
|
2020
Q1 | – | Sell |
-668
| Closed | -$202K | – | 321 |
|
|
2019
Q4 | $202K | Buy |
+668
| New | +$202K | 0.01% | 337 |
|